Disparities in risk perception and low harm reduction services awareness, access, and utilization among young people with newly reported hepatitis C infections in California, 2018
Abstract Background Newly reported hepatitis C virus (HCV) infections in California increased 50% among people 15–29 years of age between 2014 and 2016. National estimates suggest this increase was due to the opioid epidemic and associated increases in injection drug use. However, most of California...
Main Authors: | Alison R. Ohringer, David P. Serota, Rachel L. McLean, Lauren J. Stockman, James P. Watt |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-07-01
|
Series: | BMC Public Health |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12889-021-11492-3 |
Similar Items
-
Injection Drug use and Hepatitis C: Interventions in Behavioral Health Settings
by: Marie Sutton
Published: (2017-07-01) -
Temporal changes in HCV genotype distribution in three different high risk populations in San Francisco, California
by: Evans Jennifer, et al.
Published: (2011-08-01) -
Hepatitis C testing and status among opioid substitution treatment clients in New South Wales
by: Fiona L. Shand, et al.
Published: (2014-04-01) -
Understanding hepatitis B, hepatitis C and HIV among people who inject drugs in South Africa: findings from a three-city cross-sectional survey
by: Andrew Scheibe, et al.
Published: (2019-04-01) -
A Vulnerability Assessment for a Future HIV Outbreak Associated With Injection Drug Use in Illinois, 2017–2018
by: Cara Jane Bergo, et al.
Published: (2021-05-01)